Literature DB >> 16409310

Epidemiology of the functional gastrointestinal disorders diagnosed according to Rome II criteria: an Australian population-based study.

P M Boyce1, N J Talley, C Burke, N A Koloski.   

Abstract

BACKGROUND: Population-based studies of the prevalence of all functional gastrointestinal disorders (FGID) using the Rome II criteria are lacking. It is also not certain whether subjects who meet the Rome II criteria for an FGID are different in terms of demographic and psychological characteristics from those subjects meeting exclusively the more restrictive Rome I criteria. AIM: To determine whether using the more restrictive Rome I criteria would result in a more biologically determined group of FGID than when the Rome II is applied.
METHODS: Subjects included individuals aged 18 years and older (n = 1,225) from the Penrith population who were initially surveyed with the Penrith District Health Survey in 1997. Subjects were sent a self-report questionnaire that contained items on gastrointestinal symptoms applying the Rome II criteria. Subjects were also assessed on psychological and personality factors and on physical and mental functioning.
RESULTS: A total of 36.1% (n = 275) of respondents was diagnosed with an FGID according to Rome II criteria. The five most prevalent FGID were functional heartburn (10.4%), irritable bowel syndrome (8.9%), functional incontinence (7.6%), proctalgia fugax (6.5%) and functional chest pain (5.1%). Subjects meeting Rome II only criteria for FGID scored significantly higher on measures of psychological caseness and emotionality than Rome I only subjects, and these were independently associated with meeting Rome I only versus Rome II only criteria for FGID.
CONCLUSION: The Rome II criteria FGID are common and do not appear to identify a vastly different group of FGID sufferers compared with the earlier Rome I criteria.

Entities:  

Mesh:

Year:  2006        PMID: 16409310     DOI: 10.1111/j.1445-5994.2006.01006.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  30 in total

Review 1.  Irritable bowel syndrome.

Authors:  Antonella Spinelli
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

2.  Common anorectal disorders.

Authors:  Amy E Foxx-Orenstein; Sarah B Umar; Michael D Crowell
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-05

3.  Proctalgia fugax.

Authors:  Santhini Jeyarajah; Sanjay Purkayastha
Journal:  CMAJ       Date:  2012-11-26       Impact factor: 8.262

4.  The Prevalence and Impact of Overlapping Rome IV-Diagnosed Functional Gastrointestinal Disorders on Somatization, Quality of Life, and Healthcare Utilization: A Cross-Sectional General Population Study in Three Countries.

Authors:  Imran Aziz; Olafur S Palsson; Hans Törnblom; Ami D Sperber; William E Whitehead; Magnus Simrén
Journal:  Am J Gastroenterol       Date:  2017-11-14       Impact factor: 10.864

5.  Investigation of the effect of military stress on the prevalence of functional bowel disorders.

Authors:  Xian-Zhao Yu; Hai-Feng Liu; Zhen-Xue Sun
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

Review 6.  Use of Evidence-Based Herbal Medicines for Patients with Functional Gastrointestinal Disorders: A Conceptional Framework for Risk-Benefit Assessment and Regulatory Approaches.

Authors:  Gerald Holtmann; Dietmar Schrenk; Ahmed Madisch; Hans D Allescher; Gudrun Ulrich-Merzenich; Fermin Mearin; Dominique Larrey; Peter Malfertheiner
Journal:  Dig Dis       Date:  2019-11-26       Impact factor: 2.404

Review 7.  Irritable bowel syndrome.

Authors:  N J Talley
Journal:  Intern Med J       Date:  2006-11       Impact factor: 2.048

8.  The effect of tegaserod on symptoms and quality of life in korean women with irritable bowel syndrome with constipation.

Authors:  Yong Sung Kim; Suck Chei Choi; Jae Myung Park; Chang Hwan Choi; Dong Ho Lee; Hee Jung Son; In Kyung Sung; Jeong Jo Jeong; Joon Seong Lee; Ki Nam Shim; Kwang Jae Lee; Su Jin Hong; Myung-Gyu Choi
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

9.  Prevalence of mood and anxiety disorder in self reported irritable bowel syndrome (IBS). An epidemiological population based study of women.

Authors:  Arnstein Mykletun; Felice Jacka; Lana Williams; Julie Pasco; Margaret Henry; Geoffrey C Nicholson; Mark A Kotowicz; Michael Berk
Journal:  BMC Gastroenterol       Date:  2010-08-05       Impact factor: 3.067

10.  The current prevalence of irritable bowel syndrome in Asia.

Authors:  Full-Young Chang; Ching-Liang Lu; Tseng-Shing Chen
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.